Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
No source content was provided for Bexlutry, so no verified list of its side effects can be summarized here. Because Bexlutry is not a medication with recognized, published safety data available, any claims about its common, serious, or long-term reactions should be treated with caution until confirmed by its prescribing label or your pharmacist. Names can also be easily confused with similar-sounding drugs, and the details matter for dosing, interactions, and warning signs. There are several important factors to consider before assuming a symptom is drug-related, and they are explained below.
If you are experiencing new or unusual symptoms after starting any medication, guessing wastes time and can delay care you may need. A free, instant, online symptom check can help you organize what you are feeling, flag symptoms that warrant urgent attention, and prepare clear questions for your doctor or pharmacist about the medication you are taking.
Last reviewed for medical accuracy: 09/24/2026
Bexlutry (generic name brexpiprazole) is an atypical antipsychotic prescribed for schizophrenia and as an add-on treatment for major depressive disorder. Like all medications, Bexlutry can cause unwanted effects. Understanding the full spectrum of bexlutry side effects helps you and your doctor balance benefits and risks, recognize warning signs early, and manage discomfort effectively.
Common Bexlutry Side Effects
Most people tolerate Bexlutry reasonably well, but some side effects occur frequently. If these become bothersome, talk with your healthcare provider before stopping the medication.
• Weight gain
• Akathisia (feelings of inner restlessness or needing to move)
• Headache
• Fatigue or drowsiness
• Nausea or upset stomach
• Dizziness or lightheadedness
• Insomnia or trouble sleeping
Less Common Bexlutry Side Effects
These occur in fewer patients but can still affect quality of life:
• Anxiety or agitation
• Constipation
• Blurred vision
• Low blood pressure upon standing (orthostatic hypotension)
• Increased appetite
• Dry mouth
• Tremor or muscle stiffness
Serious Bexlutry Side Effects
Although rare, these reactions require immediate medical attention. If you experience any of the following, contact emergency services or go to your nearest emergency department:
• Signs of allergic reaction: hives, swelling of face/lips/tongue, difficulty breathing
• Seizures or convulsions
• High fever, stiff muscles, rapid heartbeat, sweating (possible neuroleptic malignant syndrome)
• Uncontrolled muscle movements, especially around the mouth or tongue (tardive dyskinesia)
• Severe lightheadedness or fainting
• Chest pain, rapid heart rate, or palpitations
• Confusion, severe dizziness, or sudden changes in vision
• Suicidal thoughts or unusual changes in mood or behavior
Why Side Effects Happen
Bexlutry works by affecting certain neurotransmitters (dopamine and serotonin) in the brain. While this helps reduce psychotic symptoms and improve mood, it can also disrupt other pathways, leading to side effects such as movement issues, metabolic changes, or changes in blood pressure.
Risk Factors for Increased Side Effects
Certain factors can make side effects more likely or intense:
• Higher doses of Bexlutry
• Long-term use
• Age over 65
• Pre-existing medical conditions (e.g., diabetes, high blood pressure)
• Concomitant use of other medications affecting dopamine/serotonin or blood pressure
Tips for Managing Bexlutry Side Effects
Many bexlutry side effects can be reduced with simple strategies:
• Stay hydrated and eat small, frequent meals to ease nausea.
• Rise slowly from sitting or lying positions to prevent dizziness.
• Keep a regular sleep schedule and practice good sleep hygiene for insomnia.
• Monitor your weight weekly; discuss diet or exercise plans with your doctor.
• Try relaxation techniques (deep breathing, yoga) for akathisia or anxiety.
• Chew sugar-free gum or sip water to relieve dry mouth.
• Report any muscle stiffness or tremors early—your doctor may adjust the dose.
Tracking Your Symptoms
Keep a daily log of side effects:
• Date and time each symptom occurs
• Severity on a scale of 1–10
• Any triggers you notice (food, activity, stress)
Review this log at each appointment. It helps your doctor fine-tune your dose or suggest additional treatments.
When to Call Your Doctor
Immediately contact your prescriber if you notice:
• New or worsening depression or suicidal thoughts
• Severe restlessness or inability to sit still
• Persistent or high-grade fever
• Signs of infection: sore throat, fever, unusual bleeding or bruising
• Any side effect that interferes with daily living
Free Symptom Checker
If you’re unsure whether a side effect requires medical attention, consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker. This quick tool can help you decide your next step and prepare for a conversation with your healthcare provider.
Balancing Benefits and Risks
For many people, the benefits of reduced psychotic episodes or improved mood outweigh the discomfort of side effects. Never stop or change your dose of Bexlutry without consulting your doctor. Abrupt discontinuation can worsen symptoms or lead to withdrawal effects.
Tips for a Safe Medication Routine
• Take Bexlutry exactly as prescribed, at the same time each day.
• Don’t mix with alcohol—this can worsen drowsiness and dizziness.
• Inform all your healthcare providers (dentists, specialists) you’re taking Bexlutry.
• Carry a list of your medications and dosages.
• Schedule regular follow-up visits to monitor progress and labs (e.g., blood sugar, lipids).
Special Populations
Older Adults
• May be more sensitive to sedation, dizziness, and low blood pressure.
• Higher risk of falls—use extra caution when standing.
Pregnancy and Breastfeeding
• Limited data on safety—discuss potential risks and benefits with your doctor.
Children and Adolescents
• Safety and effectiveness in under-18s have not been firmly established—use only if clearly needed.
Key Takeaways on Bexlutry Side Effects
• Common: weight gain, akathisia, headache, fatigue, nausea, dizziness, insomnia
• Less common: anxiety, constipation, blurred vision, low blood pressure, dry mouth, tremor
• Serious (rare): allergic reactions, seizures, neuroleptic malignant syndrome, tardive dyskinesia, suicidal thoughts
• Manage mild effects with lifestyle adjustments; report any severe or distressing symptoms promptly
• Use a symptom tracker or the doctor approved Ubie Symptom Checker to guide decisions
Always remember: your health matters. While bexlutry side effects can be bothersome, most are manageable with early recognition and open communication with your healthcare team. Never hesitate to reach out if something doesn’t feel right—especially if it’s life-threatening or severely impacts your daily life.
If you experience any serious or life-threatening symptoms, seek emergency medical help immediately. For all other concerns about Bexlutry or its side effects, speak to a doctor to find the safest and most effective way forward.
(References)
* Allegretti AS, Zhang W, Zhou W, Thurber TK, Rigby SP, Bowman-Stroud C, Trescoli C, Serusclat P, Freeman MW, Halvorsen YC. Safety and Effectiveness of Bexagliflozin in Patients With Type 2 Diabetes Mellitus and Stage 3a/3b CKD. Am J Kidney Dis. 2019 Sep;74(3):328-337. doi: 10.1053/j.ajkd.2019.03.417. Epub 2019 May 14. PMID: 31101403; PMCID: PMC10077840.
* Pasqualotto E, Figueiredo Watanabe JM, Gewehr DM, da Silva Maintinguer R, van de Sande-Lee S, de Araujo GN, Leal FS, Pinheiro CEA. Efficacy and safety of bexagliflozin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab. 2023 Jul;25(7):1794-1802. doi: 10.1111/dom.15051. Epub 2023 Apr 3. PMID: 36929659.
* Hadd MJ, Bienhoff SE, Little SE, Geller S, Ogne-Stevenson J, Dupree TJ, Scott-Moncrieff JC. Safety and effectiveness of the sodium-glucose cotransporter inhibitor bexagliflozin in cats newly diagnosed with diabetes mellitus. J Vet Intern Med. 2023 May-Jun;37(3):915-924. doi: 10.1111/jvim.16730. Epub 2023 May 6. PMID: 37148170; PMCID: PMC10229323.
* Cowart K, Coon S, Carris NW. A Review of the Safety and Efficacy of Bexagliflozin for the Management of Type 2 Diabetes. Ann Pharmacother. 2024 May;58(5):514-522. doi: 10.1177/10600280231190443. Epub 2023 Aug 11. PMID: 37568270.
* McMurray JJV, Solomon SD, Lock JP, Massaro JM, Zhu F, Zhou W, Skali H, Lewis EF, Freeman MW, Halvorsen YC. Meta-analysis of risk of major adverse cardiovascular events in adults with type 2 diabetes treated with bexagliflozin. Diabetes Obes Metab. 2024 Mar;26(3):971-979. doi: 10.1111/dom.15394. Epub 2023 Dec 27. PMID: 38151752.
* Stachteas P, Patoulias D, Popovic DS, Athanasiadou P, Fragakis N. Bexagliflozin as an Adjunct Therapy to Diet and Exercise to Improve Glycaemic Control in Adults with Type 2 Diabetes. touchREV Endocrinol. 2024 Apr;20(1):19-24. doi: 10.17925/EE.2024.20.1.6. Epub 2023 Dec 19. PMID: 38812664; PMCID: PMC11132653.
* Guo J, Wei M, Zhang W, Jiang Y, Li A, Wang C, Yin D, Sun A, Gong Y. Clinical efficacy and safety of sodium-glucose cotransporter protein-2 (SGLT-2) inhibitor, glucagon-like peptide-1 (GLP-1) receptor agonist, and Finerenone in type 2 diabetes mellitus with non-dialysis chronic kidney disease: a network meta-analysis of randomized clinical trials. Front Pharmacol. 2025;16:1517272. doi: 10.3389/fphar.2025.1517272. Epub 2025 Mar 27. PMID: 40213686; PMCID: PMC11983143.
* Susi IR, Viviano K, Whitehouse WH. Clinical therapeutics in feline medicine: updates for old and new drugs. J Feline Med Surg. 2025 Oct;27(10):1098612X251380011. doi: 10.1177/1098612X251380011. Epub 2025 Oct 6. PMID: 41051985; PMCID: PMC12501467.
* Prakash V, Gupta S, Singh S, Rawat A, Deshpande AV, Podder A, Jani P. Comparative Effect of SGLT2 Inhibitors and GLP-1 Agonists on Glycemic Control in Type 2 Diabetes Mellitus. J Pharm Bioallied Sci. 2025 Dec;17(Suppl 4):S3244-S3246. doi: 10.4103/jpbs.jpbs_1334_25. Epub 2025 Dec 17. PMID: 41522902; PMCID: PMC12788593.
* Gao S, Zhang F, Xie X, Fan L. Comparison of effectiveness and safety of bexagliflozin and other sodium-glucose cotransporter 2 inhibitors for type 2 diabetes mellitus in adults: systematic review and network meta-analysis of randomized controlled trials. Front Endocrinol (Lausanne). 2026;17:1843370. doi: 10.3389/fendo.2026.1843370. Epub 2026 May 13. PMID: 42211460; PMCID: PMC13212240.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.